Phase 3 Lung Cancer Trial, Not Yet Recruiting NCT07289646 Sponsor: University Hospital, Brest Condition: Lung Cancer
Back to Lung Cancer

Phase 3 Lung Cancer Trial, Not Yet Recruiting

NCT07289646
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults over 18 years old who are planned to receive a specific type of targeted radiation treatment (called SBRT) for a lung tumour — whether that tumour started in the lung or spread there from elsewhere — at one of the participating treatment centres.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to give their consent to take part in the study.
  • People who are under a legal guardianship or curatorship arrangement.
  • Women who are pregnant or breastfeeding.
  • People who have a medical reason they cannot receive the special radioactive substance used during the lung imaging scan that is part of this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026

Contact this trial

Phone: +33 2 98 22 31 17

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
University Hospital, Brest
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
31 January 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To determine whether a functional planning guided by lung perfusion PET/CT imaging is superior to a conventional anatomical planning with regards to the occurrence of grade 2 or higher lung toxicity during the year following lung SBRT.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov